Alexandre Abizaid
Latest contributions
Treating complex CAD indications with sirolimus coated balloon: evidence and performance
22 May 2025 – From EuroPCR 2025
Gain a deeper understanding of how sirolimus coated balloon (SCB) technology is shaping the treatment of complex coronary artery disease (CAD). This EuroPCR 2025 session brings together compelling clinical trial data and real-world case presentations to illustrate the safety, efficacy, and versatility of the MagicTouch SCB...
Innovative strategies for coronary interventions
22 May 2025 – From EuroPCR 2025
Explore innovative strategies in coronary interventions, including the EPIC26 sirolimus-eluting stent study, use of percutaneous ventricular assist devices in high-risk patients, the SCORE multicenter study on SeQuent SCB, DCB versus DES for ostial left circumflex lesions, and site-specific antithrombotic therapy outcomes from the DESyne BDS Plus...
360 management of cardiogenic shock
22 May 2025 – From EuroPCR 2025
This session presents a comprehensive 360-degree approach to managing cardiogenic shock, featuring long-term outcomes of low-profile ventricular assist devices, emergency ECMO implementation in PCI centers without on-site surgery, and pharmacologic strategies comparing cangrelor and ticagrelor efficacy and safety in acute myocardial infarction complicated by cardiogenic shock...
Active posterior leaflet replacement - A novel transcatheter approach for the treatment of primary and secondary mitral regurgitation
21 May 2025 – From EuroPCR 2025
Find out more about an innovative transcatheter strategy for managing both primary and secondary mitral regurgitation in this EuroPCR 2025 session. Experts introduce the concept of active posterior leaflet replacement and present the Polares MRace device—a novel solution designed to address the limitations of current therapies....
Hotline TAVI 1: extended analysis of the randomised trials
21 May 2025 – From EuroPCR 2025
Gain comprehensive insights from extended analyses of randomized TAVI trials. This session reviews five-year UK TAVI outcomes, cardiac damage evolution in asymptomatic aortic stenosis, one-year results from the LANDMARK trial, and three-year comparisons of balloon-expandable valves, highlighting critical clinical implications.
TAVI in challenging cases: pushing the limits
21 May 2025 – From EuroPCR 2025
Navigate challenging TAVI cases with this focused session emphasizing valve-in-valve procedures in complex anatomical scenarios. Learn strategies for managing TAVI in patients with multivessel disease and impaired ventricular function, and optimize procedural planning using advanced imaging, access methods, and device selection through detailed case presentations and...
Sirolimus coated balloon for coronary artery disease and peripheral artery disease treatment: the new frontier
20 May 2025 – From EuroPCR 2025
This EuroPCR 2025 session delivers a comprehensive update on the MagicTouch sirolimus-coated balloon (SCB) and its expanding role in treating both coronary and peripheral artery disease (CAD/PAD). The session covers the extensive clinical trial program supporting MagicTouch as a versatile treatment option across multiple indications. It...
Zero-contrast TAVI while using a novel full-body embolic protection filter
26 Nov 2024 – From PCR London Valves 2024
Discover the latest advancements in zero-contrast TAVI through this case-based session. Learn when to consider a zero-contrast protocol, gain practical insights on performing the procedure, and explore a novel full-body embolic protection filter designed to enhance safety during transcatheter interventions.
Featured research - Aortic valve (Part 1)
24 Nov 2024 – From PCR London Valves 2024
Dive into the latest research on aortic valve interventions in this two-part featured research session. Explore a wide range of topics, including the safety and efficacy of novel transcatheter aortic valve systems, hemodynamic outcomes, risk scoring, and peri-procedural considerations.
Insights from the top late-breaking trials at PCR London Valves 2024
24 Nov 2024 – From PCR London Valves 2024
Looking to stay ahead in transcatheter valve therapies? Don't miss out this video showcasing the most impactful late-breaking trials from PCR London Valves 2024.
Discover pivotal findings, including one-year results comparing two balloon-expandable TAVI valves, outcomes of the TRISCEND II trial for tricuspid regurgitation and groundbreaking insights...
Trial updates and featured clinical research
16 May 2024 – From EuroPCR 2024
This session showcases a selection of the latest clinical research and trial updates presented at EuroPCR 2024. Attendees will have the opportunity to learn about the findings from studies evaluating the use of OCT-guided PCI for chronic total occlusions, the safety and efficacy of short dual...
Sirolimus-coated balloon: expanding the scope of indications for complex coronary artery disease treatment
14 May 2024 – From EuroPCR 2024
Watch this session to gain case-based insights on using DCBs in complex settings. Learn valuable tips and tricks for optimal DCB application, including the best timing and situations for their use. Discover how to effectively implement a hybrid strategy that combines DES and DCB when needed.
Hotline: new coronary devices (DES, BRS, DCB)
14 May 2024 – From EuroPCR 2024
This hotline session provides a comprehensive overview of the latest clinical data on new coronary devices, including bioresorbable scaffolds, drug-coated balloons, and drug-eluting stents. Participants will learn about the outcomes of various randomized trials and registry studies, examining the performance of these innovative technologies in different...
Mechanical circulatory support in cardiogenic shock and high-risk PCI
14 May 2024 – From EuroPCR 2024
This session, comprising selected EuroPCR 2024 Abstract submissions, focuses on the use of mechanical circulatory support in cardiogenic shock and high-risk PCI. It includes presentations and discussions on lowering cardiogenic shock mortality through a comprehensive mechanical circulatory support approach, the use of lactate and lactate clearance...
PCI in patients with diabetes: next generation DES + DCB stent platform in action
14 May 2024 – From EuroPCR 2024
Watch this session on PCI in diabetic patients to learn about a groundbreaking technology addressing the complexities of this critical subgroup. Discover the next-generation DES and DCB stent platform and the innovative Envisolution technology behind it. Understand how it works, its advantages in managing complex cases,...
TAVI: From simple to complex - LIVE case
20 Nov 2023 – From PCR London Valves 2023
This session explores two clinical cases, providing valuable insights into the essential components of a straightforward and efficient TAVI procedure. Find out more about the application of innovative devices to broaden the scope of aortic valve intervention, facilitating their integration into Heart Team discussions and daily...
Late-breaking trials on latest-generation aortic valves and dedicated transcatheter devices
20 Nov 2023 – From PCR London Valves 2023
Find out the outcomes of the main studies on the latest-generation valves and devices presented at PCR LV 2023 to better determine their benefits, performance and interest in the treatment of specific aortic pathologies: REACCESS-2 Study, ACURATE Neo2 PMCF post-market registry, OCEAN-TAVI registry, ShortCut Pivotal Study, and...
Embolic protection, TAVI, heart failure and artificial intelligence: what's new in 2023
19 May 2023 – From EuroPCR 2023
This session covers various topics related to transcatheter aortic valve replacement, including the Protect Head-to-Head study on full-body embolic protection during TAVR, the FLOWer device for complete embolic protection, the use of a pulsing aspiration pump for percutaneous thrombectomy, and many more innovation updates from 2023.
The next generation DES technology: innovative DES+DCB stent platform
Next generation of DES technology, what it's all about? Find out in this session where experts will present complex cases from around the world and discuss the new indications for which they can be used.
Rapid-fire abstracts: Session 10
29 Nov 2022 – From PCR London Valves 2022
Discover a selection of abstracts presented during PCR LV 2022: trends in utilisation of percutaneous tricuspid valve vegetation debulking in endocarditis 2017-19, association of TRI-SCORE with clinical outcomes after transcatheter tricuspid valve repair, transcatheter edge-to-edge repair vs. percutaneous annuloplasty for tricuspid regurgitation, and more!
TAVI innovations
27 Nov 2022 – From PCR London Valves 2022
Discover some of the latest innovations in TAVI presented at PCR LV 2022: zero-contrast TAVI, emerging technique for coronary protection in ViV TAVR, first dedicated splitting device in a degenerated TAVR at risk for double coronary obstruction, and much more!
What's next in DES technology? Innovative DES platforms combining DES with DCB
19 May 2022 – From EUROPCR 2022
Via a series of case presentations, learn more about the dual drug delivery from DES and DCB platform to treat diabetes mellitus patients. Understand its efficiency in a complex setting and see how a no-polymer DES and DCB platform can fill the gaps of the unmet...
The cathlab of tomorrow... already here today
18 May 2022 – From EuroPCR 2022
Explore the 3 key pillars of innovation and discover how AI can improve patient safety and aid decision-making in the cathlab, what are the latest updates in robotic PCI and how it can be the transformative technology, and how technology can have a huge impact on...
Stents in challenging situations
18 May 2022 – From EuroPCR 2022
Watch this session to discover the use and outcome of a selection of abstract submissions concerning: the treatment of diffuse CAD with one long stent vs. multistents, novel uncaging bioadaptor for coronary revascularisation, one-month DAPT in high bleeding risk ACS patients and much more.
The ability to transform coronary artery disease treatment: innovative nanotechnology-based sirolimus DES and DCB platforms
18 May 2022 – From EuroPCR 2022
Alexandre Abizaid, Marco Valgimigli, Fazila Malik, Luca Testa, Patrick W. Serruys, Damiano Regazzoli, Kumar Prathap, and Sandeep Basavarajaiah take turns in this session to discuss two innovative technologies: a stent platform with nanotechnology and a novel drug-coated balloon (DCB). These novel technologies both have unique features...
Abluminus DES+: an innovative solution going global to beat diabetes
18 May 2021 – From EuroPCR 2021
Watch this session presented by Roxana Mehran, Luca Testa, Alexandre Abizaid and Marie-Claude Morice in order to know more about the need of a dedicated DES+ for diabetic patients and the technology behind it and the updates on ongoing and upcoming studies and trials, as well...
Interventional treatment for heart failure
18 May 2021 – From EuroPCR 2021
Watch this session if you want to learn about interventional techniques for monitoring and treatment of patients with heart failure and to review options for haemodynamic support in patients with acute heart failure.
This session was originally presented during EuroPCR 2021.
Addressing diabetes globally with an innovative solution
18 May 2021 – From EuroPCR 2021
Watch this session presented by Roxana Mehran, Luca Testa and Alexandre Abizaid in order to understand the need to address diabetes with a dedicated solution, to learn how the DES+DCB platform can help counter DM in PCI, and to get insights into the ongoing and upcoming clinical programs.
View...
Innovative solutions to treat diabetic patients
Watch this video if you want to understand the need of dedicated DES for Diabetes Mellitus (DM) patients, to understand and learn the differences of CAD for diabetic compared to non-diabetic patients, to see clinical evidences and results for the treatment of Diabetic patients with DES+...
PCR and TCT announce the creation of a New Educational Program: Partners in Learning
21 Jan 2020
New York, NY – Tuesday 21, 2020 – PCR and TCT are proud to announce the creation of a new educational program: “Partners in Learning”. The first of its kind will focus on TAVI practitioners, taking place on 21-22 March 2020 in Sao Paulo, Brazil. It...
